文献速递烧伤创面修复

英国和爱尔兰烧伤护理中皮肤替代物使用的临床医生调查:CASSIUS研究

A clinician survey of skin substitute use in burns care in the UK and Ireland: The CASSIUS study.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2025-01-28

该横断面调查于2022年4月24日至8月15日通过REDCap©开展,覆盖英国和爱尔兰所有烧伤单元/中心,共306名医护人员回应。结果显示皮肤替代物广泛用于急性浅二度烧伤(16/21,76%)、深二度/全层烧伤(18/21,86%)和二次重建(20/21,95%),但不用于供皮区(6/21,29%);多数产品成分识别率低于50%,高级烧伤外科医生认知显著更高;多数受访者愿意考虑参与未来随机试验。

要点

  • 皮肤替代物广泛用于急性浅二度烧伤(76%)、深二度/全层烧伤(86%)和二次重建(95%),供皮区使用较少(29%)。
  • 高级烧伤外科医生对产品成分的认知显著高于其他人员,但多数产品正确识别率不足50%。
  • 多数受访者愿意考虑将患者随机分配至未来皮肤替代物相关试验。

核心结论

  • 皮肤替代物使用广泛但单元内和单元间差异显著,需要更好的证据指导使用,理想情况下应开展比较产品的随机对照试验;产品成分知识尤其非高级烧伤外科医生有待提高。

研究设计与样本

  • 横断面调查,由重建外科试验网络通过REDCap©开发并分发,于2022年4月24日至2022年8月15日在英国和爱尔兰所有烧伤单元/中心开展,共306名医护人员回应。

主要发现

  • 高级烧伤外科医生对产品成分的知识显著更高,但不足50%的受访者能正确识别大多数产品的成分。
  • 皮肤替代物用于急性浅二度烧伤的单元/中心为16/21(76%),用于深二度/全层烧伤为18/21(86%),用于二次重建为20/21(95%),用于供皮区为6/21(29%)。
  • Biobrane是浅二度烧伤最常用的产品,Novosorb-BTM是急性深二度/全层烧伤和二次烧伤重建最常用的产品。
  • 大多数受访者报告愿意考虑将患者随机分配至未来涉及皮肤替代物的试验。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Skin substitutes are routinely used in burn surgery. Increasing numbers of marketed products, regional variation in use, and lack of high-quality research may be contributing to non-standardised care across units. Previous research has also shown that many healthcare professionals in burns care cannot correctly identify the constituents of skin substitute products, with medicolegal implications related to consent. METHODS: A cross-sectional survey of healthcare professionals across all burn units/centres in the UK and Ireland was conducted between 24/04/2022-15/08/2022. The survey was developed and distributed by the Reconstructive Surgery Trials Network using REDCap©. We evaluated current skin substitute use, clinicians' awareness of their constituents, factors influencing product selection, and feasibility of performing future randomised trials in this area. RESULTS: From all burn units and centres in the UK, 306 healthcare professionals responded. Knowledge of product constituents was significantly greater among senior burn surgeons, but <50% respondents correctly identified the constituents of most products. Skin substitutes were used by most units/centres for acute superficial partial burns (16/21, 76%), deep partial/full-thickness burns (18/21, 86%) and secondary reconstruction (20/21, 95%) but not for donor sites (6/21, 29%). Biobrane was the most used for superficial partial burns and Novosorb-BTM for acute deep partial/full-thickness burns and secondary burn reconstruction. Most respondents reported willingness to consider randomising patients to future trials involving skin substitutes. CONCLUSIONS: Skin substitute use is reportedly widespread, but there is significant intra- and inter-unit variability. Better evidence to guide use is required, ideally with randomised controlled trials comparing products. Knowledge of product constituents, particularly by non-senior burn surgeons, requires improvement.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Lee A, McKean AR, Wormald JCR, et al. A clinician survey of skin substitute use in burns care in the UK and Ireland: The CASSIUS study. J Plast Reconstr Aesthet Surg. 2025. PMID: 39938465. doi:10.1016/j.bjps.2025.01.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。